ARTICLE | Company News
BioMimetix, Duke University deal
July 25, 2011 7:00 AM UTC
The university granted newco BioMimetix an exclusive license to develop a class of patented compounds to treat radiation toxicity incurred during the treatment of cancer. Terms were not disclosed. ...